These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 13324963)

  • 21. Experiments on the immunogen prepared from killed tubercle bacilli for prophylaxis and treatment of tuberculosis.
    KUWABARA T; YAJIMA T
    Kekkaku; 1953 Jul; 28(7):[English abstract], 358. PubMed ID: 13085556
    [No Abstract]   [Full Text] [Related]  

  • 22. IN VITRO STUDIES ON THE INTERACTIONS BETWEEN MACROPHAGES OF RABBITS AND TUBERCLE BACILLI. II. CELLULAR AND HUMORAL ASPECTS OF ACQUIRED RESISTANCE.
    HSU HS
    Am Rev Respir Dis; 1965 Apr; 91():499-509. PubMed ID: 14263929
    [No Abstract]   [Full Text] [Related]  

  • 23. Antituberculous immunity induced in mice by vaccination with killed tubercle bacilli or with a soluble bacillary extract.
    WEISS DW; DUBOS RJ
    J Exp Med; 1955 Mar; 101(3):313-30. PubMed ID: 13233454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Fifty years of the history of antituberculosis killed-bacilli vaccination in humans].
    DE TONI G
    Minerva Med; 1953 Jun; 44(45):1503-12. PubMed ID: 13072081
    [No Abstract]   [Full Text] [Related]  

  • 25. [The immunology of tuberculosis].
    Tokunaga T
    Kekkaku; 1989 Feb; 64(2):121-33. PubMed ID: 2499728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antituberculosis vaccination in humans: comparison of killed and live bacilli vaccines].
    DE TONI G
    Minerva Med; 1953 Jun; 44(46):1531-40. PubMed ID: 13072086
    [No Abstract]   [Full Text] [Related]  

  • 27. The effect of various factors on the immunising power of a urea-killed tubercle vaccine.
    ILAND CN; JESPERSEN A
    Acta Pathol Microbiol Scand; 1955; 36(3):250-6. PubMed ID: 14387680
    [No Abstract]   [Full Text] [Related]  

  • 28. IMMUNIZATION with the vole bacillus.
    Vet Rec; 1946 Oct; 58(42):463. PubMed ID: 20275315
    [No Abstract]   [Full Text] [Related]  

  • 29. The immunizing properties of isoniazid-resistant tubercle bacilli in guinea-pigs.
    HAMILTON GM; NASSAU E
    Tubercle; 1955 May; 36(5):130-8. PubMed ID: 14373957
    [No Abstract]   [Full Text] [Related]  

  • 30. EXPERIMENTAL studies of vaccination, allergy, and immunity in tuberculosis. VI. Comparative effects of BCG, H37Ra, Mycobacterium phlei and a wax-protein fraction of human tubercle bacilli.
    Am J Hyg; 1955 Nov; 62(3):270-82. PubMed ID: 13268417
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparison of immunities against tuberculosis between the guinea pigs treated with dead tubercle bacilli paraffin-oil vaccine and those treated with BCG, by the method of slide cell culture.
    YAMADA S
    Sci Rep Res Inst Tohoku Univ Med; 1952 Mar; 3(3):333-48. PubMed ID: 14958412
    [No Abstract]   [Full Text] [Related]  

  • 32. [Comparative histological study of intradermoreactions to tuberculin and to lipopolysaccharide from tubercle bacilli in allergic subjects].
    KOURILSKY R; VERLEY JM; GRESLAND P
    Bull Acad Natl Med; 1960 Jan 19-26; 144():47-9. PubMed ID: 14411360
    [No Abstract]   [Full Text] [Related]  

  • 33. [Experimental immunization against tubercle bacilli; original method; preliminary note].
    FIGUEROA DE LA VEGA S; CALDERON IH
    Sem Med; 1951 Oct; 99(17):677-84. PubMed ID: 14883952
    [No Abstract]   [Full Text] [Related]  

  • 34. Studies on tubercle bacillus-monocyte relationship. III. Conditions affecting the action of serum and cells; modification of bacilli in an immune system.
    FONG J; CHIN D; AKIYAMA HJ; ELBERG SS
    J Exp Med; 1959 Jun; 109(6):523-43. PubMed ID: 13654626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IMMUNOGENIC VALUE OF KILLED ANTITUBERCULOUS VACCINE AND OF BACILLARY EXTRACTS ACCORDING TO RECENT EXPERIMENTS. INTRODUCTORY REMARKS.
    WEISS DW
    Acta Tuberc Pneumol Scand Suppl; 1964; 58():SUPPL 58:13-8. PubMed ID: 14164132
    [No Abstract]   [Full Text] [Related]  

  • 36. [Experimental immunization of the guinea pig with the Arloing-Courmont strain of the tubercle bacillus].
    GILLISSEN G; ROCHOLI G
    Z Hyg Infektionskr; 1951; 133(3):223-30. PubMed ID: 14922939
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical and experimental studies on the precipitation reactions of the sera obtained from tuberculosis patients against the antigens prepared from tubercle bacillus and timothy bacillus. II. Experimental studies on the behaviours of the antigens prepared from tubercle bacillus and timothy bacillus].
    ETO T
    Kekkaku; 1952 May; 27(5):229-33. PubMed ID: 12981736
    [No Abstract]   [Full Text] [Related]  

  • 38. Antituberculous immunity induced by methanol extracts of tubercle bacilli; its enhancement by adjuvants.
    WEISS DW; DUBOS RJ
    J Exp Med; 1956 Jan; 103(1):73-85. PubMed ID: 13278456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaccination against tuberculosis with the vole bacillus.
    WELLS AQ; WYLIE JA
    Br Med Bull; 1954; 10(2):96-100. PubMed ID: 13160417
    [No Abstract]   [Full Text] [Related]  

  • 40. Application of virulence studies to the problems of BCG immunization.
    DUBOS RJ; PIERCE CH; SUTER EW
    Bull N Y Acad Med; 1950 Jul; 26(7):507. PubMed ID: 15426884
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.